The clinical trials market in Poland  slowed in 2009, in comparison with previous years. Between 2006 and 2008, it grew at a rate of 8-10% per annum, whereas 2009 saw a year-on-year increase of only 1%, based on PMR estimates. “This poor market growth rate was, evidently, caused by the economic crisis, as a result of which companies cut down on expenditure on R&D projects, including clinical trials. On the other hand, the market is already quite saturated, which is why, according to us, it is not expected to grow at an exponential rate in the future” says Agnieszka Stawarska, a PMR Pharmaceutical Market Analyst and the report co-author. PMR forecasts that in 2010 the market will expand by around 5% year on year and will be worth PLN 718m (€170m).
(…)

Polish Business News